Diarrhea and AIDS

  • Alexa R. GaleEmail author
  • Matthew Wilson


HIV and AIDS affect over 30 million people worldwide, and diarrhea affects 28–60% of HIV-positive patients. Patients who have low CD4 counts (less than 350) are highly susceptible to a range of opportunistic infections. Approximately 50% of patients present with an infectious etiology. HIV/AIDS patients are susceptible to bacterial and parasitic causes of diarrhea – cryptosporidiosis being one of the most difficult to treat. Patients should be counseled that ensuring compliance with their protease inhibitors is key in treating their diarrhea.


Diarrhea Dehydration Abdominal pain Antibiotics HIV AIDS Cryptosporidiosis Antiretroviral therapy 


  1. 1.
    Logan C, Beadsworth M, Beeching N. HIV and diarrhea: what is new? Curr Opin Infect Dis. 2016;29(5):486–94.CrossRefGoogle Scholar
  2. 2.
    Nwachukwu CE, Okebe JU. Antimotility agents for chronic diarrhoea in people with HIV/AIDS. Cochrane Database Syst Rev. 2008;4:CD005644.Google Scholar
  3. 3.
    O’Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr. 2003;34(4):407–14.CrossRefGoogle Scholar
  4. 4.
    Carcamo C, Hooton T, Wener MH, Weiss NS, Gilman R, Arevalo J, et al. Etiologies and manifestations of persistent diarrhoea in adults with HIV-1 infection: a case-control study in Lima. Peru J Infect Dis. 2005;191(1):11–9.CrossRefGoogle Scholar
  5. 5.
    Silverberg MJ, Gore ME, French AL, Gandhi M, Glebsy MJ, Kovacs A, et al. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the women’s interagency HIV Study. Clin Infect Dis. 2004;5(1):19–24.Google Scholar
  6. 6.
    Moyle GJ, Youle M, Higgs C, Monaghan J, Prince W, Chapman S, et al. Safety, pharmacokinetics and antiretroviral activity of the poten, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and an extended follow-up in patients infected with human immunodeficiency virus. J Clin Pharmacol. 1998;38:736–43.CrossRefGoogle Scholar
  7. 7.
    Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423–30.CrossRefGoogle Scholar
  8. 8.
    DuPont AU, Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997;92(11):1962.PubMedGoogle Scholar
  9. 9.
    Call SA, Heudebert G, Saag M, Wilcox CM. The changing etiology of chronic diarrhea in HIV infected patients with CD4 cell counts less than 200 cells/mm3. Amer J Gastroenterol. 2000;95(11):3142–6.CrossRefGoogle Scholar
  10. 10.
    Dikman AE, Schonfeld E, Srisarajivakul NC, Poles MA. Human immunodeficiency virus-associated diarrhea: still an issue in the era of antiretroviral therapy. Dig Dis Sci. 2015;60(8):2236–45.CrossRefGoogle Scholar
  11. 11.
    Cello JP, Day LW. Idiopathic AID enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology. 2009;136:1952–65.CrossRefGoogle Scholar
  12. 12.
    Lew EA, Poles MA, Dieterich DT. Diarrheal diseases associated with HIV infection. Gastroenterol Clin N Am. 1997;26:259–90.CrossRefGoogle Scholar
  13. 13.
    Thoden J, Potthoff A, Bogner JR, et al. Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection. 2013;41(Suppl 2):91–115.CrossRefGoogle Scholar
  14. 14.
    Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis. 2005;40(8):1173–80.CrossRefGoogle Scholar
  15. 15.
    Abubakar I, Aliyu SH, Arumugam C, Hunter PR, Usman NK. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev. 2007;1:CD004932.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Georgetown University School of Medicine, MedStar Washington Hospital Center, Department of Emergency MedicineWashington, DCUSA

Personalised recommendations